Effects of botulinum toxin type A on contouring of the lower face

Dermatologic Surgery

Volumn 31, Issue 5, 2005, Pages 502-508

  Choe, Seong Wook ^a   Cho, Wan Ik ^a   Lee, Chang Kyun ^b   Seo, Seong Jun ^a  

^a Chung Ang University   (South Korea)

^b Gowoonsesang Dermatologic Clinic   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; ECHOGRAPHY; FEMALE; HEADACHE; HUMAN; MASSETER MUSCLE; MUSCLE HYPERTROPHY; MUSCLE MASS; OPTIMAL DRUG DOSE; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; HYPERTROPHY; INTRALESIONAL DRUG ADMINISTRATION; MALE; PATHOLOGY; RANDOMIZATION; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERTROPHY; INJECTIONS, INTRALESIONAL; MALE; MASSETER MUSCLE; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; TREATMENT OUTCOME;

EID: 20844447311     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2005.31151     Document Type: Article

References (14)

1. Dencer D. Bilateral idiopathic masseteric hypertrophy. Br J Plast Surg 1961;14:149-52.
2. von Lidern JJ, Niederhagen B, Appel T, et al. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg 2001;107:327-32.
3. Franks AS. Masticatory muscle hyperactivity and temporomandibular joint dysfunction. J Prosthet Dent 1965;15:1122-31.
4. Gurney CE. Chronic bilateral benign hypertrophy of the masseter muscles. Am J Surg 1947;73:137.
5. Beckers HL. Masseteric muscle hypertrophy and its intraoral surgical correction. J Maxillofac Surg 1977;5:28-35.
6. Wood GD. Masseter hypertrophy and its surgical correction. Br Dent J 1982;152:416-7.
7. Nishioka GJ, Montgomery MT. Masticatory muscle hyperactivity in temporomandibular disorders: is it an extrapyramidally expressed disorder? J Am Dent Assoc 1988;116:514-20.
8. To EW, Ahuja AT, Ho WS, et al. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 2001;54:197-200.
9. Klein AW. Complications and adverse reactions with the use of botulinum toxin. Semin Cutan Med Surg 2001;20:109-20.
10. Cather JC, Cather JC, Menter A. Update on botulinum toxin for facial aesthetics. Dermatol Clin 2002;20:749-61.
11. Borodic GE, Cozzolino D, Ferrante R, et al. Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy. Ophthalmol Plast Reconstr Surg 1991;7:54-60.
12. Simpson LL. Peripheral actions of the botulinum toxins. In: Simpson LL, editor. Botulinum neurotoxin and tetanus toxin. San Diego (CA): Academic Press; 1989. p. 153-78.
13. Pamphlett R. Early terminal and nodal sprouting of motor axons after botulinum toxin. J Neurol Sci 1989;92:181-92.
14. Smyth AG. Botulinum toxin treatment of bilateral masseteric hypertrophy. Br J Oral Maxillofac Surg 1994;32:29-33.